Long-Term Outcomes After Metabolic Surgery: Beyond Weight
Large cohort studies link metabolic and bariatric surgery with lower risks of some cancers and dementia, but also show risks to watch. What the data say.
Discussions of metabolic and bariatric surgery often focus on how much weight people lose in the first year or two. Over the past decade, large registry and cohort studies have followed patients for much longer and looked at outcomes beyond the scale, such as cancer and dementia. This article summarises several recent studies, gives equal weight to the risks they reveal, and explains why observational data must be read with care. Its purpose is clinical education.
Long-term outcomes: obesity-related cancer in a Nordic cohort
A 2026 study in JAMA Surgery used the Nordic Obesity Surgery Cohort, which draws on national registries in Denmark, Finland and Sweden. It included 784,105 people aged 18 to 59 with a recorded diagnosis of obesity between 1992 and 2023, of whom 99,614 had bariatric surgery. After adjustment for age, sex, calendar year, country and obesity- and lifestyle-related conditions, surgery was associated with a lower incidence of obesity-related cancers overall (adjusted incidence rate ratio 0.81). The strongest associations were for liver cancer (0.49), endometrial cancer (0.51) and ovarian cancer (0.73), and they were similar across age groups and in men and women.
Not every signal is favourable
The same study found a higher risk of pancreatic cancer after surgery (aIRR 1.19), most marked in people aged 18 to 39 (aIRR 2.21). The researchers acknowledge important limits: the design is observational, the registries did not record BMI, smoking, alcohol, diet or physical activity, and people who have surgery may be followed more closely, which can change how often cancers are found. An earlier summary of this study is linked below; this article places it alongside other long-term evidence.
Dementia and alcohol-related risk
A nationwide, propensity-matched registry study published in 2026 compared people with obesity and type 2 diabetes who had surgery with matched controls who did not. Over a mean follow-up of 9 years, the 15-year cumulative incidence of dementia was 1.8% after surgery and 2.7% in controls (subdistribution hazard ratio 0.60). Rates were lower for Alzheimer's disease (1.2% vs 1.9%) and vascular dementia (0.4% vs 0.7%). Alcohol-related dementia, however, was more common after surgery (0.2% vs 0.04%, hazard ratio 3.67). This finding suggests that alcohol use deserves attention during long-term follow-up.
Durability differs by procedure
Long-term results also depend on the operation. A PCORnet cohort of 65,093 patients in 41 US health systems reported mean total weight loss at 1 year of 31.2% after gastric bypass, 25.2% after sleeve gastrectomy and 13.7% after gastric banding, and 25.5%, 18.8% and 11.7% at 5 years. Gastric bypass had the highest 30-day rate of major adverse events (5.0%, compared with 2.6% and 2.9%). This study was also observational and had missing follow-up data.
Habits after surgery still matter
The EFIBAR randomised trial tested a 16-week supervised exercise programme starting about 10 days after surgery in 80 participants. Total weight loss at 12 months was similar with and without the programme (37.0% vs 37.2%), and short-term gains in blood pressure and HbA1c were not sustained at 12 months. This does not mean exercise lacks value: the trial measured specific outcomes over 12 months, and it suggests that one early programme is not enough on its own to change them.
Reading long-term data responsibly
Together, these studies support discussing long-term benefits beyond weight with patients, while being clear that most of the evidence is observational, that some risks (pancreatic cancer in younger adults, alcohol-related harm) need attention, and that lifelong follow-up is part of the treatment.
Related guide: Bariatric surgery and obesity related cancer risk jama study
Sources: - Radkiewicz C et al. Bariatric Surgery and Risk of Obesity-Related Cancer by Age and Sex. JAMA Surg 2026 (doi:10.1001/jamasurg.2026.4798) - Medscape report including the study limitations (October 2026) - Stenberg E, Cao Y, Eliasson B, Näslund E. The effects of bariatric surgery on dementia in patients with diabetes and obesity. Alzheimers Dement 2026;22(8):e71802 (doi:10.1002/alz.71802) - Arterburn D et al. Comparative Effectiveness and Safety of Bariatric Procedures for Weight Loss: A PCORnet Cohort Study. Ann Intern Med 2018;169(11):741-750 (doi:10.7326/M17-2786) - Martínez-Rosales E et al. Effects of supervised exercise immediately after bariatric surgery: results from the EFIBAR randomized trial. Obes Surg 2026 (doi:10.1007/s11695-026-08915-8)
This article is for general educational purposes for healthcare professionals and does not constitute medical advice. Decisions about surgery and follow-up rest with the patient and the multidisciplinary team.